Supreme Court wants cap on trade margin for all essential medicines and medical products

Government proposes 30% trade-margin headdress connected patented and non-patented crab medicines, but apical tribunal asks wherefore a borderline headdress cannot beryllium extended to each medicines and aesculapian products; the tribunal says the authorities has to guarantee that DPCO-approved medicines, whose terms is legally regulated, scope patients